Literature DB >> 34059986

Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.

Jialei Chen1,2, Ping Liu3, Wenguang Hu3, Yang Xu3, Jia Deng3.   

Abstract

OBJECTIVES: Facial nerve palsy (FNP) is extremely rare in Kawasaki disease (KD) and the incidence is just 0.9-1.3%. Our objective was to study the clinical features and prognosis of KD accompanied with FNP and to determine whether FNP indicated an increased risk of coronary artery lesions (CALs) in KD.
METHODS: An observational study was performed on 9 patients diagnosed as KD accompanied with FNP in Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China between September 2012 and December 2019. Patients were followed up from September 2012 till September 2020. Clinical features, laboratory and echocardiography findings, treatments, and prognosis were analyzed retrospectively. And the clinical data of patients with FNP (group A, n = 9) were compared to matched KD patients without FNP (group B, n = 27) in order to determine whether FNP indicated an increased risk of CALs in KD. The matching factors included sex, age, days of illness at the intravenous immunoglobulin use, and classic/incomplete KD forms.
RESULTS: Clinical data of 9 patients were analyzed in this study. Patients tended to be younger than 24 months of age (88.9%) and 55.6% were under 12 months. Median onset of FNP was day 10 of illness. Eight patients (88.9%) showed unilateral FNP. The levels of laboratory inflammatory markers (White blood cells count, neutrophil percentage, C-reactive protein, erythrocyte sedimentation rate, etc.) were significantly increased in most cases. CALs were noted in 8 of 9 patients (88.9%). Coronary artery aneurysms occurred in 4 cases (44.4%) and the remaining 4 patients showed coronary artery dilation. All patients were given intravenous immunoglobulin therapy (2 g/kg), aspirin (30-50 mg/kg/day), and short-term dexamethasone. During follow-up, both FNP and CALs were completely recovered in all patients. The duration time of FNP ranged from 10 to 130 days. And the time for CALs to normal ranged from 12 to 282 days. The occurrence of CALs was significantly higher in patients with FNP than those without FNP (88.9% vs. 25.9%, P < 0.05).
CONCLUSIONS: KD accompanied with FNP is rare but may indicate an increased risk of CALs. Clinicians should take KD into consideration when children suffer from long-term fever with FNP, even with incomplete diagnostic features. With a long-term follow-up, both FNP and CALs have a good prognosis. KEY POINTS: • Facial nerve palsy may indicate an increased risk of coronary artery lesions in Kawasaki disease. • Clinicians should take Kawasaki disease into consideration when children suffer from long-term fever with facial nerve palsy, even with incomplete diagnostic features. • Facial nerve palsy and coronary artery lesions have a good prognosis in a long-term follow-up.

Entities:  

Keywords:  Coronary artery; Facial nerve palsy; Intravenous immunoglobulin; Kawasaki disease

Year:  2021        PMID: 34059986     DOI: 10.1007/s10067-021-05791-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  Atypical Presentation of Incomplete Kawasaki Disease: A Peripheral Facial Nerve Palsy.

Authors:  Moises Rodriguez-Gonzalez; Ana Castellano-Martinez; Alvaro A Perez-Reviriego
Journal:  J Emerg Med       Date:  2018-05-03       Impact factor: 1.484

2.  Facial palsy in a 2-month-old infant with Kawasaki disease.

Authors:  Satvinder Kaur; Ketan Prasad Kulkarni; Prem Narayan Dubey
Journal:  Rheumatol Int       Date:  2009-11-11       Impact factor: 2.631

3.  Facial nerve palsy, Kawasaki disease, and coronary artery aneurysm.

Authors:  Robert C Stowe
Journal:  Eur J Paediatr Neurol       Date:  2015-06-12       Impact factor: 3.140

4.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

5.  Prospective study of Kawasaki disease complications: review of 115 cases.

Authors:  Natália Ribeiro de M Alves; Cristina Medeiros R de Magalhães; Roseane de Fátima R Almeida; Regina Cândido R Dos Santos; Lenora Gandolfi; Riccardo Pratesi
Journal:  Rev Assoc Med Bras (1992)       Date:  2011 May-Jun       Impact factor: 1.209

Review 6.  The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.

Authors:  Jane C Burns; Alessandra Franco
Journal:  Expert Rev Clin Immunol       Date:  2015       Impact factor: 4.473

7.  Facial nerve palsy and Kawasaki disease.

Authors:  Abdullah Kocabaş; Fırat Kardelen; Bilge Aldemir-Kocabaş; Gayaz Akçurin; Halil Ertuğ
Journal:  Indian J Pediatr       Date:  2013-02-20       Impact factor: 1.967

Review 8.  Kawasaki disease manifesting as bilateral facial nerve palsy and meningitis: a case report and literature review.

Authors:  Bo Zhang; Yunpeng Hao; Yanfeng Zhang; Nuo Yang; Hang Li; Jianmin Liang
Journal:  J Int Med Res       Date:  2019-07-31       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.